195 related articles for article (PubMed ID: 18082275)
1. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety.
Tan LA; Xu K; Vaccarino FJ; Lovejoy DA; Rotzinger S
Behav Brain Res; 2008 Mar; 188(1):195-200. PubMed ID: 18082275
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).
Al Chawaf A; Xu K; Tan L; Vaccarino FJ; Lovejoy DA; Rotzinger S
Peptides; 2007 Jul; 28(7):1406-15. PubMed ID: 17644218
[TBL] [Abstract][Full Text] [Related]
3. Teneurin C-terminal associated peptide (TCAP)-1 attenuates corticotropin-releasing factor (CRF)-induced c-Fos expression in the limbic system and modulates anxiety behavior in male Wistar rats.
Tan LA; Xu K; Vaccarino FJ; Lovejoy DA; Rotzinger S
Behav Brain Res; 2009 Jul; 201(1):198-206. PubMed ID: 19428634
[TBL] [Abstract][Full Text] [Related]
4. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
[TBL] [Abstract][Full Text] [Related]
5. Regulation of neurite growth in immortalized mouse hypothalamic neurons and rat hippocampal primary cultures by teneurin C-terminal-associated peptide-1.
Al Chawaf A; St Amant K; Belsham D; Lovejoy DA
Neuroscience; 2007 Feb; 144(4):1241-54. PubMed ID: 17174479
[TBL] [Abstract][Full Text] [Related]
6. Teneurin proteins possess a carboxy terminal sequence with neuromodulatory activity.
Wang L; Rotzinger S; Al Chawaf A; Elias CF; Barsyte-Lovejoy D; Qian X; Wang NC; De Cristofaro A; Belsham D; Bittencourt JC; Vaccarino F; Lovejoy DA
Brain Res Mol Brain Res; 2005 Feb; 133(2):253-65. PubMed ID: 15710242
[TBL] [Abstract][Full Text] [Related]
7. Teneurin C-terminal associated peptide (TCAP)-1 modulates dendritic morphology in hippocampal neurons and decreases anxiety-like behaviors in rats.
Tan LA; Al Chawaf A; Vaccarino FJ; Boutros PC; Lovejoy DA
Physiol Behav; 2011 Aug; 104(2):199-204. PubMed ID: 21411044
[TBL] [Abstract][Full Text] [Related]
8. Evolution of complementary peptide systems: teneurin C-terminal-associated peptides and corticotropin-releasing factor superfamilies.
Lovejoy DA; Rotzinger S; Barsyte-Lovejoy D
Ann N Y Acad Sci; 2009 Apr; 1163():215-20. PubMed ID: 19456342
[TBL] [Abstract][Full Text] [Related]
9. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of teneurin C-terminus associated peptide (TCAP)-3 from the hypothalamus of an adult rainbow trout (Oncorhynchus mykiss).
Qian X; Barsyte-Lovejoy D; Wang L; Chewpoy B; Gautam N; Al Chawaf A; Lovejoy DA
Gen Comp Endocrinol; 2004 Jun; 137(2):205-16. PubMed ID: 15158132
[TBL] [Abstract][Full Text] [Related]
11. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.
Conti LH; Murry JD; Ruiz MA; Printz MP
Psychopharmacology (Berl); 2002 May; 161(3):296-303. PubMed ID: 12021833
[TBL] [Abstract][Full Text] [Related]
12. Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization.
Kupferschmidt DA; Lovejoy DA; Rotzinger S; Erb S
Br J Pharmacol; 2011 Feb; 162(3):574-83. PubMed ID: 20883474
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
14. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
[TBL] [Abstract][Full Text] [Related]
15. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
[TBL] [Abstract][Full Text] [Related]
16. Reduced number of CRF-containing neurons in the central amygdala correlated with enhanced locomotor activity following early postnatal corticosterone treatment in the Wistar rat.
Roskoden T; Hanke J; Yilmazer-Hanke D; Schwegler H
Behav Brain Res; 2005 Dec; 165(2):221-8. PubMed ID: 16144721
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats.
Conti LH
Eur J Pharmacol; 2005 Jan; 507(1-3):125-34. PubMed ID: 15659302
[TBL] [Abstract][Full Text] [Related]
18. Repeated intravenous administrations of teneurin-C terminal associated peptide (TCAP)-1 attenuates reinstatement of cocaine seeking by corticotropin-releasing factor (CRF) in rats.
Erb S; McPhee M; Brown ZJ; Kupferschmidt DA; Song L; Lovejoy DA
Behav Brain Res; 2014 Aug; 269():1-5. PubMed ID: 24768621
[TBL] [Abstract][Full Text] [Related]
19. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
Erb S; Kayyali H; Romero K
Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
[TBL] [Abstract][Full Text] [Related]
20. Expression and actions of corticotropin-releasing factor/diuretic hormone-like peptide (CDLP) and teneurin C-terminal associated peptide (TCAP) in the vase tunicate, Ciona intestinalis: Antagonism of the feeding response.
D'Aquila AL; Hsieh AH; Hsieh AH; De Almeida R; Lovejoy SR; Lovejoy DA
Gen Comp Endocrinol; 2017 May; 246():105-115. PubMed ID: 27292788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
